FNMA Stock Alert 08/28/2014 20:32:53 $FNMA No way, 3.88 is

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
FNMA Stock Alert 08/28/2014 20:32:53 $FNMA
No way, 3.88 is much more accurate.
As per my analysis tomorrow might close at 3,89-3,91

FNMA Stock Message Board http://investorshangout.com/Fannie-Mae-FNMA-61730/

FHFA/Watt is a tool for the Treasury. Treasury will not give up the stolen cash cow without a fight. Everything will have to be proven in court or the discovery must be damaging enough for them to settle. Why would Treasury help prove that FnF can stand up and walk by themselves by allowing uplist, recapitalization, release or ceasing the sweep? All in good time. The hedgies are smart and have the $$ to retain the best legal firms. Sucks to wait but it will be sooo worth it in the end.
Fannie Mae unable to dispel NYSE listing news.

Re-posting this great blog post

http://timhoward717.com/2014/08/28/fannie-mae...ting-news/
http://news.yahoo.com/doj-money-bank-america-...07619.html
Very hypocritical, FHFA sues all these banks and wins yet will not release FnF or stop the sweep so they can build capital and reserves. They know who really was at fault but keep FnF locked up like they are the plague.
Hopefully they'll bump nomura and RBS will get moved up too

Yes sir, they all do.
Aweoe good news. They'll settle
Lei sic m sic tang Gwong Dong Wa? DIU LEI !!!!!!!!!
How ironic...or should I say hypocritical...the FHFA are suing, and have settled with a lot of banks for defrauding FnF. But when it comes to FnF...FHFA claims they are the guilty party in the mortgage fraud world. And they expect us to trust them....what a crock of political hogwash.
HSBC, Nomura Lose Bid to Block U.S. Regulator Lawsuits
Bob Van VorisAug 28, 2014 6:33 pm ET

(Updates with FHFA claims in sixth paragraph.)

Aug. 28 (Bloomberg) -- HSBC Holdings Plc and Nomura Holdings Inc. lost a bid to block claims by a U.S. regulator the banks say were brought too late, clearing the way for a trial of HSBC over questionable mortgage practices.

U.S. District Judge Denise Cote today reaffirmed earlier rulings that claims by the Federal Housing Finance Agency, which sued the banks over residential mortgage-backed securities sold to Fannie Mae and Freddie Mac, aren’t barred by laws limiting the time in which suits must be filed.

The ruling allows the FHFA to go forward with a trial next month in which HSBC could be found liable for as much as $1.6 billion, according to the bank. It also puts added pressure on HSBC to settle. Nomura’s trial is scheduled for next year.

FHFA sued 18 banks in 2011 over losses to Fannie Mae and Freddie Mac on securities backed by risky mortgages. All but three of the banks -- HSBC, Nomura and Royal Bank of Scotland Group Plc -- have settled. Goldman Sachs Group Inc. last week agreed to pay $3.15 billion to buy back mortgage-backed securities to settle FHFA claims against it. Goldman Sachs was also scheduled to begin trial next month.

Robert Sherman, a spokesman for London-based HSBC, and Jonathan Hodgkinson, a spokesman for Chuo-Ku, Japan-based Nomura, declined to comment on the ruling.

False Statements

The FHFA said the banks defrauded Fannie Mae and Freddie Mac by making false statements about the quality of the loans underlying the securities. The regulator claimed the banks violated U.S. securities laws in addition to the laws of Virginia and the District of Columbia.

The FHFA sued more than three years after Fannie Mae and Freddie Mac bought the mortgage-backed securities, between Nov. 30, 2005, and July 3, 2007. The federal Securities Act requires claims to be made within three years. The Washington law has a three-year limit and the Virginia law a two-year limit, according to Cote. The banks said the claims were filed too late.

Cote ruled against motions to dismiss in cases involving UBS AG, HSBC and Nomura. UBS, Switzerland’s biggest bank, agreed in July 2013 to pay $885 million to settle the FHFA claims.

Cote ruled that the Housing and Economic Recovery Act of 2008 extended the time the FHFA could file claims. A federal appeals court in New York agreed with Cote, upholding her ruling in the UBS case.

HSBC and Nomura renewed their arguments after the U.S. Supreme Court in June issued its ruling in an environmental case involving CTS Corp. Cote ruled today that the CTS case doesn’t affect her rulings on the timing of the FHFA cases.

The case is Federal Housing Finance Agency v. HSBC North America Holdings Inc., 11-cv-06189, U.S. District Court, Southern District of New York (Manhattan).
http://washpost.bloomberg.com/Story?docId=137...R038OJ7CI3

Agreed
Tough one to figure out...he seems like an intelligent person.

Perhaps the mind is brainwashed and now closed.


Mikoli007

I agree I respect the constitution and abide by the laws of our country but both are being violated by our elected and appointed officials My attitude towards them is a reflection of their actions and leadership. They have not earned or deserve my respect Go Fannie. GLTA.
Big yank,
One thing you said was true...you do fail to see.
Good call HollyK-Also we can have respect for the U.S. Constitution, nowhere do I feel obligated nor necessary to have respect for a lot of politicians especially you little danky because you sound like one!
Good job Geo and Always. It amazes me how stupid big yank sounds in it's arguments. It's like listening to rich spoiled brat 3rd grader demanding he get his way because his parents are powerful so he begs for candy because he thinks money grows on trees and mommy and daddy have endless supplies of it and can do whatever they want when they want. Right up until someone slaps the snot out of him for being a spoiled brat!
When can we expect to hear something (ANYTHING) from
The Judge ?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 5

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Security: The Fast Guard App Revolution

Updated Category News Views 109

Transforming Security with the Fast Guard App Fast Guard Service, a prominent name in licensed security guard services, has introduced a cutting-edge solution for the construction and property management sectors. This newly enhanced Fast Guard App empowers users to swiftly order and manage essential security services, including fire watch and armed or unarmed guards,...

Continue Reading
Weak Demand and Global Issues Impact China's Industries

Updated Category Economy Views 428

China's Industrial Profits Accelerate in June China's industrial gains in June increased more quickly, a reflection of good economic trends despite underlying problems. Official figures revealed a 3.6% year-on-year rise in profits, against a 0.7% increase in May. Strong industry output, according to the National Bureau of Statistics (NBS), helped to explain this increase....

Continue Reading
CyberArk Marks a Decade of Growth and Innovation Since IPO

Updated Category News Views 222

CyberArk Celebrates a Decade Since Its IPO In a significant milestone, CyberArk, a leader in identity security, marks ten years since its Initial Public Offering (IPO) on the NASDAQ. This anniversary serves as a moment for reflection and highlights essential achievements throughout the company's growth. Ringing the NASDAQ Bell to Honor Their Journey On the day of the...

Continue Reading
Projected Growth of the Biosurgery Market to $21.59 Billion

Updated Category News Views 145

Biosurgery Market Overview The global biosurgery market, currently valued at approximately US$14.96 billion, is expected to grow to a remarkable US$21.59 billion by a specified target year. This substantial growth, projected at an impressive CAGR of 6.4%, is fueled primarily by the urgent need for effective management of blood loss during surgical procedures and the rise...

Continue Reading
MIND Technology, Inc. Reports Growth Amidst Market Challenges

Updated Category News Views 188

Overview of MIND Technology's Recent Performance MIND Technology, Inc. (NASDAQ: MIND) has recently unveiled its financial outcomes for the third quarter of fiscal 2026. The company achieved revenues amounting to approximately $9.7 million during this period. Comparative Revenue Analysis This figure reflects a notable decrease from the $13.6 million realized in the prior...

Continue Reading